During the past decade, Princess Margaret Hospital conducted 674 clinical trials. In the 10-year time frame, 674 clinical trials started and 286 clinical trials were completed, i.e. on average, 42.4% percent of trials that started reached the finish line to date. In the past 5 years, 237 clinical trials started and 141 clinical trials were completed. i.e. 59.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Princess Margaret Hospital" #1 sponsor was "University Health Network, Toronto" with 383 trials, followed by "National Cancer Institute (NCI)" with 104 trials sponsored, "NCIC Clinical Trials Group" with 82 trials sponsored, "Hoffmann-La Roche" with 64 trials sponsored and "Radiation Therapy Oncology Group" with 64 trials sponsored. Other sponsors include 786 different institutions and companies that sponsored additional 289 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Princess Margaret Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 157 trials as a collaborator, "Princess Margaret Hospital, Canada" with 79 trials as a collaborator, "NRG Oncology" with 25 trials as a collaborator, "NCIC Clinical Trials Group" with 24 trials as a collaborator and "SWOG Cancer Research Network" with 21 trials as a collaborator. Other collaborators include 721 different institutions and companies that were collaborators in the rest 327 trials.

According to Clinical.Site data, the most researched conditions in "Princess Margaret Hospital" are "Breast Cancer" (89 trials), "Prostate Cancer" (88 trials), "Multiple Myeloma" (55 trials), "Ovarian Cancer" (52 trials) and "Lung Cancer" (47 trials). Many other conditions were trialed in "Princess Margaret Hospital" in a lesser frequency.

Most popular intervention types in "Princess Margaret Hospital" are "Drug" (1032 trials), "Other" (201 trials), "Biological" (189 trials), "Radiation" (176 trials) and "Procedure" (160 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (82 trials), "Laboratory Biomarker Analysis" (55 trials), "Pembrolizumab" (50 trials), "Cisplatin" (48 trials) and "radiation therapy" (48 trials). Other intervention names were less common.

The vast majority of trials in "Princess Margaret Hospital" are 1132 trials for "All" genders, 186 trials for "Female" genders and 157 trials for "Male" genders.

Currently, there are 554 active trials in "Princess Margaret Hospital". 8 are not yet recruiting, 265 are recruiting, 276 are Active, not recruiting, and 5 are Enrolling by invitation. In total, there were 761 completed trials in Princess Margaret Hospital, 4 suspended trials, and 114 terminated clinical trials to date.

Out of the total trials that were conducted in Princess Margaret Hospital, 361 "Phase 1" clinical trials were conducted, 577 "Phase 2" clinical trials and 397 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 10 trials, and there were also 167 trials that are defined as “Not Applicable".